Ruboxistaurin Reduces Cocaine-Stimulated Increases in Extracellular Dopamine by Modifying Dopamine-Autoreceptor Activity

Alexander G. Zestos; Colleen Carpenter; Youngsoo Kim; Malcolm J. Low; Robert T. Kennedy; Margaret E. Gnegy

doi:10.1021/acschemneuro.8b00259

journal article Nov 01, 2018

Ruboxistaurin Reduces Cocaine-Stimulated Increases in Extracellular Dopamine by Modifying Dopamine-Autoreceptor Activity

Alexander G. Zestos

Colleen Carpenter Youngsoo Kim

Malcolm J. Low Robert T. Kennedy

Margaret E. Gnegy

ACS Chemical Neuroscience Vol. 10 No. 4 pp. 1960-1969 · American Chemical Society (ACS)

View at Publisher Save 10.1021/acschemneuro.8b00259

Topics

No keywords indexed for this article. Browse by subject →

References

66

[1]

10.1016/j.chc.2016.02.004

[2]

10.1074/jbc.m413887200

[3]

10.1124/jpet.108.147959

[4]

10.1021/acschemneuro.6b00028

[5]

10.1016/0028-3908(92)90048-t

[6]

10.1002/syn.10223

[7]

10.1002/(sici)1098-2396(199707)26:3<281::aid-syn9>3.0.co;2-3

[8]

10.1124/mol.66.1.137

[9]

10.1016/s0014-2999(99)00828-6

[10]

Kantor L. J Pharmacol Exp Ther (1998) 10.1016/s0022-3565(24)37287-8

[11]

10.1111/j.1471-4159.2010.06788.x

[12]

10.1074/jbc.m112.407874

[13]

10.1074/jbc.m200294200

[14]

10.1371/journal.pbio.0020078

[15]

10.1016/s0028-3908(98)00022-7

[16]

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

Jean-Martin Beaulieu, Raul R. Gainetdinov

Pharmacological Reviews 10.1124/pr.110.002642

[17]

10.1016/j.baga.2016.02.001

[18]

10.1007/bf00175709

[19]

10.1038/nn.2862

[20]

10.1038/npp.2014.336

[21]

10.1111/j.1460-9568.2010.07591.x

[22]

10.1016/0028-3908(93)90023-v

[23]

Cubeddu L. X. J. Pharmacol Exp Ther (1989) 10.1016/s0022-3565(25)20863-1

[24]

10.1074/jbc.m408319200

[25]

10.1016/j.neuropharm.2014.10.012

[26]

10.1016/0028-3908(92)90049-u

[27]

10.1016/j.brainres.2011.11.024

[28]

10.1016/j.neuropharm.2015.01.002

[29]

Cubeddu L. J. Pharmacol. Exp. Ther. (1983) 10.1016/s0022-3565(25)21482-3

[30]

10.1016/s0924-977x(97)00098-9

[31]

10.1007/s00213-003-1691-8

[32]

10.1016/0091-3057(95)00167-u

[33]

10.1073/pnas.1608362113

[34]

10.1523/jneurosci.0918-12.2012

[35]

10.1210/me.2007-0202

[36]

10.1111/j.1471-4159.1993.tb02185.x

[37]

10.1016/0304-3940(94)90096-5

[38]

10.1124/mol.106.027763

[39]

10.1124/mol.59.1.113

[40]

10.1111/jnc.12229

[41]

10.1016/s0006-8993(98)00146-2

[42]

10.1046/j.1471-4159.1995.64031161.x

[43]

10.1016/0006-8993(91)90731-a

[44]

10.1038/npp.2014.30

[45]

10.1016/0014-2999(86)90459-0

[46]

10.1111/j.1471-4159.2006.04358.x

[47]

10.1038/377424a0

[48]

10.1016/j.neuroscience.2013.06.035

[49]

10.1007/s00213-002-1142-y

[50]

10.1002/jnr.22821

Showing 50 of 66 references

Metrics

13

Citations

66

References

Details

Published: Nov 01, 2018
Vol/Issue: 10(4)
Pages: 1960-1969

Authors

A

Alexander G. Zestos

Department of Chemistry and Center for Behavioral Neuroscience, American University, Washington, D.C. 20016, United States

Department of Radiology, Hanyang University Guri Hospital, Hanyang University, Guri, Korea.

University of Michigan, Ann Arbor, MI

M

Margaret E. Gnegy

Funding

National Institute of Diabetes and Digestive and Kidney Diseases Award: R01 DK066604

Howard Hughes Medical Institute

National Institute of Biomedical Imaging and Bioengineering Award: R01 EB003320

National Institute on Drug Abuse Award: T32 DA007268

American University

Cite This Article

Alexander G. Zestos, Colleen Carpenter, Youngsoo Kim, et al. (2018). Ruboxistaurin Reduces Cocaine-Stimulated Increases in Extracellular Dopamine by Modifying Dopamine-Autoreceptor Activity. ACS Chemical Neuroscience, 10(4), 1960-1969. https://doi.org/10.1021/acschemneuro.8b00259

Ruboxistaurin Reduces Cocaine-Stimulated Increases in Extracellular Dopamine by Modifying Dopamine-Autoreceptor Activity

You May Also Like